Medisyn Technologies

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

Medisyn Technologies, Inc., a biotechnology company, develops pre-qualified proprietary drug compounds. Its Forward Engineering platform is used for producing compounds for breast, renal, prostate, and lung-cancer treatments. The company also analyzes and optimizes existing drugs, and develops new drug candidates for its partners. In addition, it offers testing and analysis services to predict safety and efficacy of compounds. The company serves biotech and pharmaceutical companies. Medisyn Technologies, Inc. was founded in 1999 and is headquartered in Minnetonka, Minnesota.